U.K. Celiac Disease Market to 2032

Overview

The U.K. Celiac Disease Market is expected to reach a 13.20 USD Million by 2032 and is projected to grow at a CAGR of 9.67% from 2025 to 2032.

Revenue, 2024 (USD Million)
7.30
Forecast, 2032 (USD Million)
13.20
CAGR, 2024 - 2032
9.67%
Report Coverage
U.K.

U.K. Celiac Disease Market 2018-2032 USD Million

U.K. Celiac Disease Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 7.30 USD Million
  • Projected Market Size (2032): 13.20 USD Million
  • CAGR (2025-2032): 9.67%

Key Findings of U.K. Celiac Disease Market

  • The U.K. Celiac Disease Market was valued at 7.30 USD Million in 2024.
  • The U.K. Celiac Disease Market is likely to grow at a CAGR of 9.67% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Prescription in Prescription Segment accounted for the largest share of the market with a revenue of 6.80 USD Million
  • The fastest growing segment Adults in Population Segment grew Fastest with a CAGR of 10.47% during the forecast period from 2024 to 2032.

U.K. Celiac Disease Market Scope

U.K. Celiac Disease Market Segmentation & Scope
Diseases
  • Refractory Celiac Disease
  • Potential Celiac Disease
  • Non-Classical Celiac Disease
  • Classical Celiac Disease
  • Dermatitis Herpetiformis
Treatment
  • Others
  • Immunosuppressants
  • Corticosteriods
Route of Administration
  • Oral
  • Intravenous
  • Topical
Dosage Form
  • Others
  • Injections
  • Capsules
  • Tablet
Prescription
  • Over The Counter
  • Prescription
Drug
  • Branded
  • Generics
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
End User
  • Others
  • Home Care Settings
  • Clinics
  • Hospitals
Population
  • Geriatric
  • Children
  • Adults

U.K. Celiac Disease Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 7.30 USD Million
Market Value in 2032 13.20 USD Million
CAGR (2025-2032) 9.67%
Historic Data 2016-2023
Market Segments Covered Diseases,Treatment,Route of Administration,Dosage Form,Prescription,Drug,Distribution Channel,End User,Population

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 7.30 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 7.30 USD Million in 2024.

Segments and Scope

  • U.K. Celiac Disease Market to 2032, By Diseases
    • Refractory Celiac Disease is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 3.99 USD Million in the year 2024.
    • Refractory Celiac Disease is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 10.25 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Treatment
    • Corticosteriods is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 5.23 USD Million in the year 2024.
    • Corticosteriods is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 9.91 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Route of Administration
    • Oral is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 5.63 USD Million in the year 2024.
    • Oral is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 10.13 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Dosage Form
    • Tablet is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 5.69 USD Million in the year 2024.
    • Tablet is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 9.95 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Prescription
    • Prescription is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 6.80 USD Million in the year 2024.
    • Prescription is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 9.87 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Drug
    • Generics is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 5.92 USD Million in the year 2024.
    • Generics is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 9.78 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Distribution Channel
    • Hospital Pharmacy is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 5.06 USD Million in the year 2024.
    • Hospital Pharmacy is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 10.12 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By End User
    • Hospitals is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 5.07 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 10.11 % in forecast period 2025-2032.
  • U.K. Celiac Disease Market to 2032, By Population
    • Adults is the largest segment in U.K. Celiac Disease Market to 2032 with a revenue of 4.60 USD Million in the year 2024.
    • Adults is the Fastest growing segment in U.K. Celiac Disease Market to 2032 with a Growth rate of 10.47 % in forecast period 2025-2032.

U.K. Celiac Disease Market Company Share Analysis

 
U.K. Celiac Disease Market Company Share Analysis
U.K. Celiac Disease Market Company Share Analysis

U.K. Celiac Disease Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Celiac Disease Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Celiac Disease Market Company Profiling

U.K. Celiac Disease Market Company Profiling
Frequently Asked Questions
The U.K. Celiac Disease Market is segmented based on Segmentation Diseases,Treatment,Route of Administration,Dosage Form,Prescription,Drug,Distribution Channel,End User,Population.
U.K. Celiac Disease Market was valued at USD 7.30(Revenue in USD Million) in 2022.
U.K. Celiac Disease Market is projected to grow at a CAGR of 9.67% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the U.K. Celiac Disease Market, holding a largest market share of 6.80 USD Million in 2024

U.K. Celiac Disease Market Scope

U.K. Celiac Disease Market Segmentation & Scope
Diseases
  • Refractory Celiac Disease
  • Potential Celiac Disease
  • Non-Classical Celiac Disease
  • Classical Celiac Disease
  • Dermatitis Herpetiformis
Treatment
  • Others
  • Immunosuppressants
  • Corticosteriods
Route of Administration
  • Oral
  • Intravenous
  • Topical
Dosage Form
  • Others
  • Injections
  • Capsules
  • Tablet
Prescription
  • Over The Counter
  • Prescription
Drug
  • Branded
  • Generics
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
End User
  • Others
  • Home Care Settings
  • Clinics
  • Hospitals
Population
  • Geriatric
  • Children
  • Adults
Frequently Asked Questions
The U.K. Celiac Disease Market is segmented based on Segmentation Diseases,Treatment,Route of Administration,Dosage Form,Prescription,Drug,Distribution Channel,End User,Population.
U.K. Celiac Disease Market was valued at USD 7.30(Revenue in USD Million) in 2022.
U.K. Celiac Disease Market is projected to grow at a CAGR of 9.67% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Celiac Disease Market for final year is USD 13.20 (USD Million).

U.K. Celiac Disease Market Company Profiling

U.K. Celiac Disease Market Company Profiling
Frequently Asked Questions
The U.K. Celiac Disease Market is segmented based on Segmentation Diseases,Treatment,Route of Administration,Dosage Form,Prescription,Drug,Distribution Channel,End User,Population.
U.K. Celiac Disease Market was valued at USD 7.30(Revenue in USD Million) in 2022.
U.K. Celiac Disease Market is projected to grow at a CAGR of 9.67% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Celiac Disease Market for final year is USD 13.20 (USD Million).

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.